Hypothyroidism And Hyperthyroidism Flashcards

1
Q

The metabolism of virtually all nucleated cells of many tissues is controlled by what hormones

A

Thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Overactivity or under-activity of which gland is the most common of all endocrine problems

A

Thyroid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the anatomy of the thyroid gland

A

The thyroid gland consists of two lateral lobes connected by
an isthmus. It is closely attached to the thyroid cartilage and to the upper end of the trachea, and thus moves on swal-
lowing. It is often palpable in normal women.
Embryologically it originates from the base of the tongue
and descends to the middle of the neck. Remnants of thyroid
tissue can sometimes be found at the base of the tongue
(lingual thyroid) and along the line of descent. The gland has a rich blood supply from superior and inferior thyroid arteries.
The thyroid gland consists of follicles lined by cuboidal
epithelioid cells. Inside is the colloid (the iodinated glycopro-
tein thyroglobulin) which is synthesized by the follicular cells.
Each follicle is surrounded by basement membrane, between
which are parafollicular cells containing calcitonin-secreting
C cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two hormones synthesized by the thyroid gland

A

Triiodothyronine (T3), which acts at the cellular level
L-thyroxine (T4), which is the prohormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the physiology behind thyroid hormone synthesis

A

Inorganic iodide is trapped by the gland by an enzyme dependent system, oxidized and incorporated into the glycoprotein thyroglobulin to form mono- and diodotyrosine and then T4 and Tz (Fig. 19.16).
More T4 than T3 is produced, but T4 is converted in some peripheral tissues (liver, kidney and muscle) to the more active T3 by 5’-monodeiodination; an alternative 3’-mono-deiodination yields the inactive reverse T3 (rTs). The latter step occurs particularly in severe non-thyroidal illness (see below).
In plasma, more than 99% of all T4 and Ty is bound to hormone-binding proteins (thyroxine-binding globulin, TBG; thyroid-binding prealbumin, TBPA; and albumin). Only free hormone is available for action in the target tissues, where Ty binds to specific nuclear receptors within target cells.
Many drugs and other factors affect TBG; all may result in confusing total T4 levels in blood, and most laboratories therefore now measure free T4 levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is the hypothalamic-pituitary-thyroid axis controlled

A

Thyrotrophin-releasing hormone (TH), a peptide produced in the hypothalamus, stimulates the pituitary to secrete thyroid-stimulating hormone (TSH). TSH in turn stimulates growth and activity of the thyroid follicular cells via the G-protein coupled TSH membrane receptor (see Table
19.3). The T3 and T4 subsequently secreted into the circulation by follicular cells exert negative feedback on the hypothalamus.

Circulating Ta is peripherally deiodinated to T which binds to the thyroid hormone nuclear receptor (TR) on target organ cells to cause modified gene transcription. There are two TR receptors (TR-a and TR-B) and the tissue-specific effects of Ty are dependent upon the local expression of these TR receptors. TR-a knockout mice show poor growth, bradycardia and hypothermia, whilst TR-B knockout mice show thyroid hyperplasia and high Ta levels in the presence of inappropriately normal circulating TSH, suggesting a role for the latter receptors in thyroid hormone resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the dietary iodine requirement

A

Globally, dietary iodine deficiency is a major cause of thyroid disease, as iodine is an essential requirement for thyroid hormone synthesis. The recommended daily intake of iodine should be at least 140 Mg, and dietary supplementation of salt and bread has reduced the number of areas where ‘endemic goitre’ still occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe thyroid function tests

A

Immunoassays for free T4, free T3 and TSH are widely avail-able. There are only minor circadian rhythms, and measurements may be made at any time. Particular uses of the tests are summarized in Table 19.13, with typical findings in common disorders.
TSH measurement
In most circumstances, TSH levels can discriminate between hyperthyroidism, hypothyroidism and euthyroidism (normal thyroid gland function). Exceptions are hypopituitarism, and the ‘sick euthyroid’ syndrome where low levels (which normally imply hyperthyroidism) occur in the presence of low or normal T4 and T levels. As a single test of thyroid function TSH is the most sensitive in most circumstances, but accurate diagnosis requires at least two tests, e.g. TSH plus free Ta or free Ts where hyperthyroidism is suspected, TSH plus serum free T4 where hypothyroidism is likely.
TRH test
This has been rendered almost obsolete by modern sensitive
TSH assays except for investigation of hypothalamic-pituitary dysfunction. TRH (protirelin) is occasionally used to differentiate between thyroid hormone resistance and TSHoma in the context of raised fT and TSH levels. Typically, after TH administration there is a rise in TSH in thyroid hormone resist-ance, whilst in TSHoma there is a flat response due to continued autonomous TSH secretion which does not respond to TRH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some problems in the interpretation of thyroid function tests

A
  1. Serious acute or chronic illness
    Thyroid function is affected in several ways:
    • Reduced concentration and affinity of binding proteins
    • Decreased peripheral conversion of T4 to Ts with more rTs
    • Reduced hypothalamic-pituitary TSH production.
    Systemically ill patients can therefore have an apparently low total and free T4 and Tz with a normal or low basal TSH (the ‘sick euthyroid’ syndrome). Levels are usually only mildly below normal and are thought to be mediated by interleukins IL-1 and IL-6; the tests should be repeated after resolution of the underlying illness.
  2. Pregnancy and oral contraceptives
    These lead to greatly increased TBG levels and thus to high or high-normal total T4. Free Ta is usually normal. Normal ranges for free T4 and TSH alter with the normal physiological changes during pregnancy and TSH is often slightly suppressed in the first trimester, but this rarely causes clinical problems.
  3. Drugs
    Amiodarone decreases T4 to T3 conversion and free Ta levels may therefore be above normal in a euthyroid patient; conversely amiodarone may induce both hyper- and hypothyroidism - the TSH level is usually reliable.
    Many drugs affect thyroid function tests by interfering with protein binding but this now rarely causes a problem with free T4 assays.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are anti thyroid antibodies

A

Serum antibodies to the thyroid are common and may be either destructive or stimulating; both occasionally co-exist in the same patient. Destructive antibodies are directed against the microsomes or against thyroglobulin; the antigen for thyroid microsomal antibodies is the thyroid peroxidase (TPO) enzyme.
TPO antibodies are found in up to 20% of the normal population, especially older women, but only 10-20% of these develop overt hypothyroidism.
TSH receptor IgG antibodies (TRAb) typically stimulate, but occasionally block, the receptor; they can be measured in two ways:
• By the inhibition of binding of TSH to its receptors (TSH-binding inhibitory immunoglobulin, TBIl)
• By demonstrating that they stimulate the release of cyclic AMP (thyroid-stimulating immunoglobulin/antibody TSI, TSAb).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pathophysiology of hypothyroidism

A

Underactivity of the thyroid is usually primary, from disease of the thyroid, but may be secondary to hypothalamic-pituitary disease (reduced TSH drive).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some causes of primary hypothyroidism

A

Atrophic (autoimmune) hypothyroidism. This is the most common cause of hypothyroidism and is associated with antithyroid autoantibodies leading to lymphoid infiltration of the gland and eventual atrophy and fibrosis. It is six times more common in females and the incidence increases with age. The condition is associated with other autoimmune disease such as pernicious anemia, vitiligo and other endocrine deficiencies (p. 939). Occasionally intermittent hypothyroidism occurs with subsequent recovery; antibodies which block the TSH receptor may sometimes be involved in the aetiology.
Hashimoto’s thyroiditis. This form of autoimmune thyroiditis, again more common in women and most common in late middle age, produces atrophic changes with regeneration, leading to goitre formation. The gland is usually firm and rubbery but may range from soft to hard. TPO antibodies are present, often in very high titres (>1000 IU/L). Patients may be hypothyroid or euthyroid, though they may go through an initial toxic phase, ‘Hashi-toxicity’. Levothyroxine therapy may shrink the goitre even when the patient is not hypothyroid.
Postpartum thyroiditis. This is usually a transient phenomenon observed following pregnancy. It may cause hyperthyroidism, hypothyroidism or the two sequentially. It is believed to result from the modifications to the immune system necessary in pregnancy, and histologically is a lymphocytic thyroiditis. The process is normally self-limiting, but when conventional antibodies are found there is a high chance of this proceeding to permanent hypothyroidism.
Postpartum thyroiditis may be misdiagnosed as postnatal depression, emphasizing the need for thyroid function tests in this situation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some defects of thyroid hormone synthesis

A

lodine deficiency. Dietary iodine deficiency still exists in some areas as ‘endemic goitre’ where goitre, occasionally massive, is common. The patients may be euthyroid or hypothyroid depending on the severity of iodine deficiency.
The mechanism is thought to be borderline hypothyroidism leading to TSH stimulation and thyroid enlargement in the face of continuing iodine deficiency.
Dyshormonogenesis. This rare condition is due to genetic defects in the synthesis of thyroid hormones; patients develop hypothyroidism with a goitre. One particular familial form is associated with sensorineural deafness due to a deletion mutation in chromosome 7, causing a defect of the transporter pendrin (Pendred’s syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some clinical features of hypothyroidism

A

Hypothyroidism produces many symptoms. The alternative term ‘myxoedema’ refers to the accumulation of mucopoly-saccharide in subcutaneous tissues. The classic picture of the slow, dry-haired, thick-skinned, deep-voiced patient with weight gain, cold intolerance, bradycardia and constipation makes the diagnosis easy. Milder symptoms are, however, more common and hard to distinguish from other causes of nonspecific tiredness. Many cases are detected on biochemical screening.
Special difficulties in diagnosis may arise in certain circumstances:
• Children with hypothyroidism may not show classic features but often have a slow growth velocity, poor school performance and sometimes arrest of pubertal development.
• Young women with hypothyroidism may not show obvious signs. Hypothyroidism should be excluded in all people with oligomenorrhoea/amenorrhoea, menorrhagia, infertility or hyperprolactinaemia.
• The elderly show many clinical features that are difficult to differentiate from normal ageing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some investigations for primary hypothyroidism

A

Serum TSH is the investigation of choice; a high TSH level confirms primary hypothyroidism. A low free T4 level confirms the hypothyroid state (and is also essential to exclude TSH deficiency if clinical hypothyroidism is strongly suspected and TSH is normal or low).
Thyroid and other organ-specific antibodies may be pres-ent. Other abnormalities include the following:

• Anaemia, which is usually normochromic and normocytic in type but may be macrocytic (sometimes this is due to associated pernicious anaemia) or microcytic (in women, due to menorrhagia)
• Increased serum aspartate transferase levels, from muscle and/or liver
• Increased serum creatine kinase levels, with associated myopathy
• Hypercholesterolaemia and hypertriglyceridaemia
• Hyponatraemia due to an increase in ADH and impaired free water clearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the clinical improvement for hypothyroidism

A

Replacement therapy with levothyroxine (thyroxine, i.e. T4) is given for life. The starting dose will depend upon the severity of the deficiency and on the age and fitness of the patient, especially their cardiac performance: 100 mg daily for the young and fit, 50 Mg (increasing to 100 Mg after 2-4 weeks) for the small, old or frail. People with ischaemic heart disease require even lower initial doses, especially if the hypothyroidism is severe and longstanding. Most physicians would then begin with 25 Mg daily and perform serial ECGs, increasing the dose at 3- to 4-week intervals if angina does not occur or worsen and the ECG does not deteriorate. Occasional patients develop ‘thyrotoxic’ (hyperthyroid) symptoms despite normal fT4 levels if dose if increased too rapidly.
Monitoring. The aim is to restore T4 and TSH to well within the normal range. Adequacy of replacement is assessed clinically and by thyroid function tests after at least 6 weeks on a steady dose. If serum TSH remains high, the dose of T4 should be increased in increments of 25-50 g with the tests repeated at 6-8 weeks intervals until TSH becomes normal.
Complete suppression of TSH should be avoided because of the risk of atrial fibrillation and osteoporosis. The usual maintenance dose is 100-150 ug given as a single daily dose. An annual thyroid function test is recommended - this is usually performed in the primary care setting, often assisted and prompted by district thyroid registers’.

Clinical improvement on T4 may not begin for 2 weeks or more, and full resolution of symptoms may take 6 months.
The necessity of lifelong therapy must be emphasized and the possibility of other autoimmune endocrine disease devel-oping, especially Addison’s disease or pernicious anaemia, should be considered. During pregnancy, an increase in T4 dosage of about 25-50 ug is often needed to maintain normal TSH levels, and the necessity of optimal replacement during pregnancy is emphasized by the finding of reductions in cognitive function in children of mothers with elevated TSH during pregnancy.
A few people with primary hypothyroidism complain of incomplete symptomatic response to T4 replacement. Combination T4 and T3 replacement has been advocated in this context, but randomized clinical trials show no consistent benefit in quality of life symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is borderline hypothyroidism or ‘compensated euthyroidism’

A

Patients are frequently seen with low-normal serum Ta levels and slightly raised TSH levels. Sometimes this follows surgery or radioactive iodine therapy when it can reasonably be seen as ‘compensatory’. Treatment with levothyroxine is normally recommended where the TSH is consistently above 10 mU/L, or when possible symptoms, high-titre thyroid antibodies, or lipid abnormalities are present. Where the TSH is only marginally raised, the tests should be repeated 3-6 months later.
Conversion to overt hypothyroidism is more common in men or when TPO antibodies are present. In practice, vague symptoms in people with marginally elevated TSH (below 10 mU/L) rarely respond to treatment, but a ‘therapeutic trial’ of replacement may be needed to confirm that symptoms are unrelated to the thyroid. It is also considered best to normalize TSH during (and ideally before) pregnancy to avoid fetal adverse effects.

18
Q

What is myxoedema coma

A

Severe hypothyroidism, especially in the elderly, may present with confusion or even coma. Myxoedema coma is very rare: hypothermia is often present and the patient may have severe cardiac failure, pericardial effusions, hypoventilation, hypoglycaemia and hyponatraemia. The mortality was previously at least 50% and patients require full intensive care.
Optimal treatment is controversial and data lacking; most physicians would advise T3 orally or intravenously in doses of 2.5-5 ug every 8 hours, then increasing as above. Large intravenous doses should not be used. Additional measures, though unproven, should include:
• Oxygen (by ventilation if necessary)
• Monitoring of cardiac output and pressures
• Gradual rewarming
• Hydrocortisone 100 mg i.V. 8-hourly
• Glucose infusion to prevent hypoglycaemia.

19
Q

What is myxoedema madness

A

Depression is common in hypothy-roidism. Rarely, with severe hypothyroidism in the elderly, the patient may become frankly demented or psychotic, sometimes with striking delusions. This may occur shortly after starting T4 replacement.

20
Q

How do you screen for hypothyroidism

A

The incidence of congenital hypothyroidism is approximately 1 in 3500 births. Untreated, severe hypothyroidism produces permanent neurological and intellectual damage (‘cretinism’). Routine screening of the newborn using a blood spot, as in the Guthrie test, to detect a high TSH level as an indicator of primary hypothyroidism is efficient and cost-effective; cretinism is prevented if Ta is started within the first few months of life.
Screening of elderly patients for thyroid dysfunction has a low pick-up rate and is controversial and not currently recommended. However, patients who have undergone thyroid surgery or received radioiodine should have regular thyroid function tests, as should those receiving lithium or amiodarone therapy.

21
Q

What is hyperthyroidism

A

Hyperthyroidism (thyroid overactivity, thyrotoxicosis) is common, affecting perhaps 2-5% of all females at some time and with a sex ratio of 5:1, most often between the ages of 20 and 40 years. Nearly all cases (>99%) are caused by intrinsic thyroid disease; a pituitary cause is extremely rare

22
Q

What is the most common cause of hyperthyroidism

A

Graves’ disease

23
Q

What is Graves’ disease

A

This is the most common cause of hyperthyroidism and is due to an autoimmune process. Serum IgG antibodies bind to TSH receptors in the thyroid, stimulating thyroid hormone production, i.e. they behave like TSH. These TSH receptor antibodies (TSHR-Ab) are specific for Graves’ disease.

Persistent high levels predict a relapse when drug treatment is stopped. There is an association with HLA-B8, DR3 and DR2 and a 40% concordance rate amongst monozygotic twins with a 5% concordance rate in dizygotic twins. There is a weak association with cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), HLA-DRB08 and DRB30202 on chromosome 6.
Yersinia enterocolitica, Escherichia coli and other Gram-negative organisms contain TSH binding sites. This raises the possibility that the initiating event in the pathogenesis may be an infection with possible ‘molecular mimicry’ in a genetically susceptible individual, but the precise initiating mechanisms remain unproven in most cases.
Thyroid eye disease accompanies the hyperthyroidism in many cases (see below) but other components of Graves’ disease, e.g. Graves’ dermopathy, are very rare. Rarely lymphadenopathy and splenomegaly may occur. Graves’ disease is also associated with other autoimmune disorders such as pernicious anemia, vitiligo and myasthenia gravis.
The natural history is one of fluctuation, many patients showing a pattern of alternating relapse and remission; perhaps only 40% of subjects have a single episode. Many patients eventually become hypothyroid.

24
Q

What are some other causes of hyperthyroidism/thyrotoxicosis

A

Solitary toxic adenoma/nodule
Toxic multinodular goitre.
de Quervain’s thyroiditis
Postpartum thyroiditis
Amiodarone-induced thyrotoxicosis

25
Q

What is solitary toxic adenoma

A

This is the cause of about 5% of cases of hyperthyroidism.
It does not usually remit after a course of antithyroid drugs.

26
Q

What is toxic multi nodular goitre

A

This commonly occurs in older women. Again, antithyroid drugs are rarely successful in inducing a remission, although they can control the hyperthyroidism.

27
Q

What is de Quervain’s thyroiditis

A

This is transient hyperthyroidism from an acute inflammatory process, probably viral in origin. Apart from the toxicosis, there is usually fever, malaise and pain in the neck with tachycardia and local thyroid tenderness. Thyroid function tests show initial hyperthyroidism, the erythrocyte sedimentation rate (ESR) and plasma viscosity are raised, and thyroid uptake scans show suppression of uptake in the acute phase.
Hypothyroidism, usually transient, may then follow after a few weeks. Treatment of the acute phase is with aspirin, using short-term prednisolone in severely symptomatic cases.

28
Q

What is amidarone-induced thyrotoxicosis

A

Amiodarone, a class III antiarrhythmic drug (see p. 699), causes two types of hyperthyroidism.
Type I amiodarone-induced thyrotoxicosis (AIT) is associated with pre-existing Graves’ disease or multinodular goitre. In this situation hyperthyroidism is probably triggered by the high iodine content of amiodarone.
Type II AlT is not associated with previous thyroid disease and is thought to be due to a direct effect of the drug on thyroid follicular cells leading to a destructive thyroiditis with release of T4 and T¿. Type II AIT may be associated with a hypothyroid phase several months after presentation.
Because amiodarone inhibits the deiodination of Ta to T3, biochemical presentation of both types of AIT may be associated with higher Ta:Ts ratios than usual.

29
Q

What are some clinical features of hyperthyroidism

A

The symptoms and signs of hyperthyroidism affect many systems (Fig. 19.18).
Symptomatology and signs vary with age and with the underlying aetiology.
• The eye signs, of lid lag and ‘stare’ may occur with hyperthyroidism of any cause but other features of thyroid eye disease (see below) occur only in Graves’ disease.
• Graves’ dermopathy is rare: pretibial myxoedema is an infiltration of the skin on the shin. Thyroid acropachy is very rare and consists of clubbing, swollen fingers and periosteal new bone formation.
In the elderly, a frequent presentation is with atrial fibrillation, other tachycardias and/or heart failure, often with few other signs. Thyroid function tests are mandatory in any patient with atrial fibrillation.
Children frequently present with excessive height or excessive growth rate, or with behavioural problems such as hyperactivity. They may also show weight gain rather than loss.
• So-called ‘apathetic thyrotoxicosis’ in some elderly patients presents with a clinical picture more like hypothyroidism. There may be very few signs and a high degree of clinical suspicion is essential.

30
Q

What are some differential diagnosis of hyperthyroidism

A

Hyperthyroidism is often clinically obvious but treatment should never be instituted without biochemical confirmation.
Differentiation of the mild case from anxiety states may be difficult; useful positive clinical markers are eye signs, a diffuse goitre, proximal myopathy and wasting. Weight loss, despite a normal or increased appetite, is a very useful clinical symptom of hyperthyroidism. The hyperdynamic circulation with warm peripheries seen with hyperthyroidism can be contrasted with the clammy hands of anxiety.

31
Q

What are some investigations for hyperthyroidism

A

• Serum TSH is suppressed in hyperthyroidism
(0.05 mU/L), except for the very rare instances of TSH hypersecretion.
• A raised free Ta or Ts confirms the diagnosis;
Ta is almost always raised but Ts is more sensitive as there are occasional cases of isolated T3 toxicosis’.
• Thyroid peroxidase (TPO) and thyroglobulin antibodies are present in most cases of Graves’ disease.
TSHR-Ab are not measured routinely, but are commonly present: thyroid-stimulating immunoglobulin (TSI) 80% posi-tive, TSH-binding inhibitory immunoglobulin (TBII) 60-90% in Graves’ disease

32
Q

What are the treatments for hyperthyroidism

A

Three possibilities are available: antithyroid drugs, radioiod-ine and surgery. Practices and beliefs differ widely within and between countries.

33
Q

Mention some anti-thyroid drugs

A

Carbimazole is most often used in the UK, and propylthiou-racil (PTU) is also used. Thiamazole (methimazole), the active metabolite of carbimazole, is used in the USA. These drugs inhibit the formation of thyroid hormones and also have other minor actions; carbimazole/thiamazole is also an immunosuppressive agent. Initial doses and side-effects are detailed

Radioactive iodine
Radioactive iodine (RAI) is given to patients of all ages, although it is contraindicated in pregnancy and while breast-feeding. RAI is the most common treatment modality in the USA whereas antithyroid drugs tend to be favoured in Europe.
13’lodine is given in an empirical dose (usually 200-
550 MBq) because of variable uptake and radiosensitivity of the gland. It accumulates in the thyroid and destroys the gland by local radiation although it takes several months to be fully effective.
Patients must be rendered euthyroid before treatment.
They should stop antithyroid drugs at least 4 days before radioiodine, and not recommence until 3 days after radio-iodine. Patients on PTU should stop antithyroid medication earlier than those on carbimazole before RAI because it has a radioprotective action. Many patients do not need to restart antithyroid medication after treatment.

34
Q

Describe surgery as a treatment for hyperthyroidism

A

Thyroidectomy should be performed only in patients who have previously been rendered euthyroid. Conventional practice is to stop the antithyroid drug 10-14 days before operation and to give potassium iodide (60 mg three times daily), which reduces the vascularity of the gland.
The operation should be performed only by experienced surgeons to reduce the chance of complications:
Early postoperative bleeding causing tracheal
compression and asphyxia is a rare emergency requiring immediate removal of all clips/sutures to allow escape of the blood/haematoma.
• Laryngeal nerve palsy occurs in 1%. Vocal cord movement should be checked preoperatively. Mild hoarseness is more common and thyroidectomy is best avoided in professional singers.
• Transient hypocalcaemia occurs in up to 10% but with permanent hypoparathyroidism in fewer than 1%.
• Ongoing thyroid function depends on the operation performed. With a single toxic nodule excision of the lesion is curative. With Graves’ disease or multinodular goitre the traditional ‘subtotal’ thyroidectomy, aiming for euthyroidism on no treatment, results in recurrent hyperthyroidism in 1-3% within 1 year, then 1% per year and hypothyroidism in about 10% of patients within 1 year, and then increasing with time. ‘Near-total’ thyroidectomy is therefore now preferred with inevitable hypothyroidism but a much reduced risk of recurrence.
Indications for either surgery or radioiodine are given in
Box 19.4.

35
Q

What are some special situations that could occur in a hyperthyroidism

A

Thyroid crisis or ‘thyroid storm’
Hyperthyroidism in pregnancy and neonatal life
The fetus and maternal Graves’ disease

36
Q

What is a thyroid storm

A

This rare condition, with a mortality of 10%, is a rapid deterioration of hyperthyroidism with hyperpyrexia, severe tachy-cardia, extreme restlessness, cardiac failure and liver dysfunction. It is usually precipitated by stress, infection or surgery in an unprepared patient, or radioiodine therapy. With careful management it should no longer occur and most cases referred as ‘crisis’ are simply severe but uncomplicated thyrotoxicosis.

37
Q

What is the treatment for a thyroid storm

A

Treatment is urgent. Propranolol in full doses is started immediately together with potassium iodide, antithyroid drugs, corticosteroids (which suppress many of the manifestations of hyperthyroidism) and full supportive meas-ures. Control of cardiac failure and tachycardia is also necessary.
Occasionally, hyperthyroidism can lead to a thyrotoxic cardiomyopathy which causes ischaemic changes on a 12-lead ECG which reverse after reversion to euthyroidism.

38
Q

Describe hyperthyroidism in pregnancy and neonatal life

A

Since hyperthyroidism typically affects young women, pregnancies, both planned and unplanned, inevitably occur during antithyroid treatment. PT is usually the preferred antithyroid drug during pregnancy or in any woman planning pregnancy, due to rare reports of congenital abnormalities with carbimazole which have not been described with PTU.
The high level of HCG found in normal pregnancy is a weak stimulator of the TSH receptor, commonly causing suppressed TSH with slightly elevated fT/fT in the first trimester which may be associated with hyperemesis gravidarum. True maternal hyperthyroidism occurring de novo during pregnancy is however uncommon and usually mild. Diagnosis can be difficult because of the overlap with symptoms of normal pregnancy and misleading thyroid function tests, although TSH is largely reliable. The pathogenesis is almost always
Graves’ disease.
Thyroid-stimulating immunoglobulin (TSI) crosses the placenta to stimulate the fetal thyroid. Carbimazole and PTU (see below) also cross the placenta, but T4 does so poorly, so a ‘block-and-replace’ regimen is contraindicated. The smallest dose necessary of PTU (see above) is used and the fetus must be monitored. If necessary (high doses needed, poor patient compliance or drug side-effects), surgery can be performed, preferably in the second trimester. Radioactive iodine is absolutely contraindicated.

39
Q

What is maternal Graves’ disease and how does it affect the fetus

A

Any mother with a history of Graves’ disease may have circulating TSI. Even if she is euthyroid after surgery or RAl, the immunoglobulin may still be present to stimulate the fetal thyroid, and the fetus can thus become hyperthyroid.
Any such patient should therefore be monitored during pregnancy. Fetal heart rate provides a direct biological assay of fetal thyroid status, and monitoring should be performed at least monthly. Rates above 160/minute are strongly suggestive of fetal hyperthyroidism, and maternal treatment with PTU and/or propranolol is used. Direct measurement of TSHR-Ab may be helpful to predict neonatal thyrotoxicosis in this situation. To prevent a euthyroid mother becoming hypothyroid, Ta may be given as this does not easily cross the placenta. Sympathomimetics, used to prevent premature labour, are contraindicated as they may provoke fatal tachycardia in the fetus. The paediatrician should be informed and the infant checked immediately after birth - overtreatment with PTU or carbimazole can cause fetal goitre. Breastfeeding while on usual doses of carbimazole or PTU appears to be safe.
Hyperthyroidism may also develop in the neonatal period as TSI has a half-life of approximately 3 weeks. Manifestations in the newborn include irritability, failure to thrive and persisting weight loss, diarrhoea and eye signs. Thyroid function tests are difficult to interpret as neonatal normal ranges vary with age.
Untreated neonatal hyperthyroidism is probably associated with hyperactivity in later childhood.

40
Q

What is thyroid hormone resistance

A

Thyroid hormone resistance is an inherited condition caused by an abnormality of the thyroid hormone receptor. Mutations to the receptor (TR B) result in the need for higher levels of thyroid hormones to achieve the same intracellular effect.
As a result, the normal feedback control mechanisms (see Fig. 19.2, p. 941) result in high blood levels of T4 with a normal TSH in order to maintain a euthyroid state. This has two consequences:
1. Thyroid function tests appear abnormal even when the patient is euthyroid and requires no treatment. Specialist review is required to differentiate from hyperthyroidism due to inappropriate TSH secretion.
2. Different tissues contain different thyroid hormone receptors and, in some families, receptors in certain tissues may have normal activity. In this case the level of thyroid hormones to maintain euthyroidism at pituitary and hypothalamic levels (which controls secretion of TSH) may be higher than that required in other tissues such as heart and bone, so that these tissues may exhibit ‘thyrotoxic’ effects in spite of a normal serum TSH. This ‘partial thyroid hormone resistance’ can be very difficult to manage effectively.

41
Q

What are some possible king-term consequences for hyperthyroidism

A

Long-term follow-up studies of hyperthyroidism show a slight increase in overall mortality, which affects all age groups, is not fully explained and tends to occur in the first year after diagnosis. Thereafter, the only long-term risk of adequately treated hyperthyroidism appears to be an increased risk of osteoporosis. People with persistently suppressed TSH levels have an increased likelihood of developing atrial fibrillation which may predispose to thromboembolic disease.